Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results